drugset / Trial / NCT01180049

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

NCT01180049

Phase 4 Completed 101 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will compare the effectiveness and safety of two different doses of temsirolimus (Torisel).

Timeline

Start
2011-03
Primary completion
2015-11
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Temsirolimus Small molecule 75 mg Intravenous

Indications